Radiopharm Theranostics: A unique cancer treatment with solid early trial results 

Listen to Radiopharm Theranostics Managing Director Riccardo Canevari talk to Matt Birney on the Bulls N’ Bears Report about Radiopharm’s UK trial for its cancer treatment that is designed to seek and destroy tumours.

Radiopharm Theranostics: A unique cancer treatment with solid early trial results 
Listen to Radiopharm Theranostics Managing Director Riccardo Canevari talk to Matt Birney on the Bulls N’ Bears Report about Radiopharm’s UK trial for its cancer treatment that is designed to seek and destroy tumours.

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N’ Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia’s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N&rsquo; Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia&rsquo;s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Advertisement